Headway For Profit

Headway has developed Occiflex, a treatment table geared to the professional market. Occiflex takes advantage of the current techniques of physical therapists and frees up caregivers’ time to provide effective treatment to multiple patients simultaneously. Pain, stiffness, and disability are reduced as Occiflex mobilizes the head and neck in 3-dimensional space, with each treatment tailored to the patient’s particular condition. Occiflex provides a safe, noninvasive and cost-effective therapeutic solution that will allow more patients to receive treatment, while providing caregivers with additional income. This method is equally effective for headaches (ranging from tension-type to post-traumatic to migraine), combined head and pain syndromes like WAD (Whiplash-Associated Disorder), myofascial pain and cervicogenic headache.

Funding Status: Early Stage Venture
Industry: NeuroTech
Estimated Revenue: $105.9 million
Technology: Neuromodulation
Headquarters: Ono, Tel Aviv, Israel
Employee Number: 51-100
Founded Date: 2006-01-01